肝脏 ›› 2026, Vol. 31 ›› Issue (9): 1314-1318.

• 肝癌 • 上一篇    下一篇

多模态MRI参数在肝脏肿瘤良恶性鉴别中的应用

杨帆, 程宜涛, 王立志, 林伟欣   

  1. 236200 阜阳 颍上县人民医院影像科(杨帆,程宜涛,王立志);
    213000 常州 常州市武进中医院放射科(林伟欣)
  • 收稿日期:2025-03-15 出版日期:2026-09-30 发布日期:2026-11-16
  • 通讯作者: 林伟欣,Email: frankxyx@163.com

Application of multiparametric MRI in differentiating benign and malignant hepatic tumors

Yang Fan1, Cheng Yitao1, Wang Lizhi1, Lin Weixin2   

  1. 1. Department of Imaging, Yingshang County People's Hospital, Fuyang 236200, China;
    2. Department of Radiology, Wujin Hospital of Traditional Chinese Medicine, Changzhou 213000, China
  • Received:2025-03-15 Online:2026-09-30 Published:2026-11-16
  • Contact: Lin Weixin, Email: frankxyx@163.com

摘要: 目的 探讨多模态磁共振成像(MRI)参数在肝脏肿瘤良恶性鉴别中的应用价值,并分析常规MRI征象、动态增强特征及弥散加权成像(DWI)/体素内不相干运动(IVIM)参数的诊断效能。方法 纳入2023年1月至2025年12月在颍上县人民医院和常州市武进中医院接受MRI检查并经病理或影像随访确诊的肝血管瘤(HH)44例、局灶性结节性增生(FNH)68例、肝细胞癌(HCC)55例及肝转移瘤34例。比较各组临床资料及MRI征象差异,测量表观弥散系数(ADC)及灌注分数(f值)。采用logistic回归分析筛选肝脏肿瘤良恶性的独立影响因素,并通过受试者工作特征(ROC)曲线评估各参数及联合模型的诊断效能。结果 各组在年龄、病灶直径、AFP水平、肝功能指标及MRI征象方面差异均有统计学意义(均P<0.05)。其中,HCC组年龄明显高于HH组及FNH组,为(58.9±11.2)岁比(45.2±10.6)岁、(38.7±9.4)岁,AFP水平显著升高,为356(78,1 250)ng/mL比3.8(2.2,6.1)ng/mL、4.5(2.8,6.9)ng/mL(P<0.05)。常规MRI显示,良性病变多表现为边界清晰、形态规则,而恶性病变多伴边界不规则及坏死。动态增强MRI中,HH以渐进性强化为主(90.3%),FNH多表现为持续强化(88.1%),而HCC及转移瘤多呈门静脉期洗脱表现(82.3%、58.1%)。DWI/IVIM分析显示,良性病变ADC值及f值显著高于恶性病变,其中HH组ADC值最高,为(1.98±0.32)×10-3 mm2/s,转移瘤组最低,为(0.98±0.18)×10-3 mm2/s;FNH组f值最高(35.8±7.2)%,转移瘤组最低(20.7±4.8)%(均P<0.05)。多因素logistic回归分析表明,门静脉期洗脱(OR=8.59,95%CI:3.41~21.62)、环形强化(OR=6.62,95%CI:2.73~16.02)及ADC值(OR=0.09,95%CI:0.03~0.25)为肝脏肿瘤良恶性鉴别的独立影响因素(均P<0.05)。ROC分析显示,多模态MRI联合模型诊断效能最高,AUC为0.95,灵敏度为90.2%,特异度为88.6%。结论 多模态MRI参数能够从形态学、弥散及灌注等多个层面反映肝脏肿瘤的生物学特性,在肝脏肿瘤良恶性鉴别中具有较高诊断价值。多参数联合分析可显著提高诊断效能,为临床无创诊断提供重要依据。

关键词: 多模态磁共振成像, 肝血管瘤, 局灶性结节性增生, 肝细胞癌

Abstract: Objective To investigate the value of multiparametric magnetic resonance imaging (MRI) in differentiating benign and malignant hepatic tumors, and to evaluate the diagnostic performance of conventional MRI features, dynamic contrast-enhanced characteristics, and diffusion-weighted imaging (DWI)/intravoxel incoherent motion (IVIM) parameters. Methods A total of 201 patients from the Yingshang County People's Hospital and Wujin Hospital of Traditional Chinese Medicine with hepatic lesions confirmed by pathology or imaging follow-up were retrospectively included, comprising 44 cases of hepatic hemangioma (HH), 68 cases of focal nodular hyperplasia (FNH), 55 cases of hepatocellular carcinoma (HCC), and 34 cases of liver metastases. Conventional MRI, DWI and/or dynamic contrast-enhanced scanning were performed. Clinical characteristics and MRI features were compared among groups. Apparent diffusion coefficient (ADC) and perfusion fraction (f value) were measured. Logistic regression analysis was performed to identify independent predictors for differentiating benign and malignant tumors. Receiver operating characteristic (ROC) curve analysis was used to evaluate the diagnostic performance of individual parameters and the combined model. Results Significant differences were observed among the groups in age, lesion diameter, AFP levels, liver function indices, and MRI features (all P<0.05). The HCC group was significantly older than the HH and FNH groups [(58.9±11.2) years vs. (45.2±10.6) years and (38.7±9.4) years], and AFP levels were markedly elevated [356 (78, 1 250) ng/mL vs. 3.8 (2.2, 6.1) ng/mL and 4.5 (2.8, 6.9) ng/mL, P<0.05]. Conventional MRI showed that benign lesions were more likely to present with well-defined margins and regular morphology, whereas malignant lesions were frequently associated with irregular borders and necrosis. On dynamic contrast-enhanced MRI, HH predominantly exhibited progressive enhancement (90.3%), FNH mainly showed persistent enhancement (88.1%), while HCC and metastatic tumors commonly demonstrated portal venous washout patterns (82.3% and 58.1%, respectively). DWI/IVIM analysis revealed that ADC and f values were significantly higher in benign lesions than in malignant lesions. The highest ADC value was observed in the HH group [(1.98±0.32) ×10-3 mm2/s], whereas the lowest was found in the metastatic tumor group [(0.98±0.18) ×10-3 mm2/s]. The highest f value was observed in the FNH group (35.8±7.2)%, while the lowest was observed in the metastatic tumor group (20.7±4.8)% (all P<0.05). Multivariate logistic regression analysis demonstrated that portal venous washout (OR=8.59, 95%CI: 3.41~21.62), rim enhancement (OR=6.62, 95%CI: 2.73~16.02), and ADC value (OR=0.09, 95%CI: 0.03~0.25) were independent predictors for differentiating benign and malignant hepatic tumors (all P<0.05). ROC analysis showed that the combined multiparametric MRI model achieved the highest diagnostic performance, with an AUC of 0.95, sensitivity of 90.2%, and specificity of 88.6%. Conclusion Multiparametric MRI can comprehensively reflect the biological characteristics of hepatic tumors from morphological, diffusion, and perfusion perspectives, and has high diagnostic value in differentiating benign and malignant lesions. The combined analysis of multiple parameters significantly improves diagnostic performance and provides an important basis for noninvasive clinical diagnosis.

Key words: Multiparametric MRI, Hepatic hemangioma, Focal nodular hyperplasia, Hepatocellular carcinoma